Literature DB >> 32048052

Effect of postoperative hypoalbuminemia and supplement of human serum albumin on the development of surgical site infection following spinal fusion surgery: a retrospective study.

Fu Zhang1, Xiaonan Liu2, Zhiwen Tan3, Jianjun Li3, Dianwa Fu4, LiXin Zhu5.   

Abstract

PURPOSE: To determine the association between postoperative hypoalbuminemia and the development of surgical site infection (SSI) and evaluate whether the supplement of exogenous human serum albumin (HSA) in patients following spinal surgery would decrease the rate of postoperative SSI.
METHODS: We performed a retrospective review of all patients who underwent lumbar spinal fusion surgery in our institution between January 2014 and December 2018. Patients with postoperative SSI were identified. We reviewed the demographic and clinical records of the patients and performed multiple logistic regression models to clarify the relevance between postoperative hypoalbuminemia, the supplement of HSA and SSI. Statistical adjustment for the potential confounders was also performed to exclude possible variation.
RESULTS: Twenty-four of 602 patients developed SSI after lumbar spinal fusion surgery. No statistical significance was found between postoperative hypoalbuminemia and SSI rate (OR 0.74; 95% CI 0.22-2.48; P = 0.6199). However, the supplement of exogenous HSA was significantly associated with increased postoperative SSI rate (OR 1.21; 95% CI 1.05-1.41; P = 0.0094). Interestingly, stratified analyses showed supplement of HSA in patients without postoperative hypoalbuminemia increased the risk of SSI (OR 2.55; 95% CI 1.01-6.45; P = 0.0475), compared with patients with postoperative hypoalbuminemia (OR 1.17; 95% CI 1.00-1.36; P = 0.0434).
CONCLUSIONS: The present study suggests that postoperative hypoalbuminemia is not associated with the development of SSI after spinal surgery. However, the supplement of HSA following spinal surgery will increase the rate of SSI. These slides can be retrieved under Electronic Supplementary Material.

Entities:  

Keywords:  Human serum albumin; Postoperative hypoalbuminemia; Surgical site infection

Mesh:

Substances:

Year:  2020        PMID: 32048052     DOI: 10.1007/s00586-020-06306-w

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  6 in total

1.  Risk factors for deep surgical site infection following posterior instrumented fusion for degenerative diseases in the thoracic and/or lumbar spine: a multicenter, observational cohort study of 2913 consecutive cases.

Authors:  Satoshi Ogihara; Takashi Yamazaki; Michio Shiibashi; Hirotaka Chikuda; Toru Maruyama; Kota Miyoshi; Hirohiko Inanami; Yasushi Oshima; Seiichi Azuma; Naohiro Kawamura; Kiyofumi Yamakawa; Nobuhiro Hara; Jiro Morii; Rentaro Okazaki; Yujiro Takeshita; Sakae Tanaka; Kazuo Saita
Journal:  Eur Spine J       Date:  2021-01-29       Impact factor: 3.134

2.  What Level Should Preoperative Albumin of Thoracic and Lumbar Tuberculosis Patients Be Reached: A Case-Controlled Study.

Authors:  Guanyin Jiang; Yong Zhu; Wei Luo; Wei Zhang; Wanyuan Qin; Yunsheng Ou
Journal:  Front Nutr       Date:  2022-04-27

Review 3.  Hypoalbuminemia as Surrogate and Culprit of Infections.

Authors:  Christian J Wiedermann
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

4.  The risk factors for the postoperative pulmonary infection in patients with hypertensive cerebral hemorrhage: A retrospective analysis.

Authors:  Shihai Xu; Bo Du; Aijun Shan; Fei Shi; Jin Wang; Manying Xie
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

5.  Value of Postoperative Serum Albumin to Predict Postoperative Complication Severity in Spinal Tuberculosis.

Authors:  Guanyin Jiang; Xing Du; Yong Zhu; Muzi Zhang; Wanyuan Qin; Tuotuo Xiong; Yunsheng Ou
Journal:  Biomed Res Int       Date:  2022-02-09       Impact factor: 3.411

6.  Predictive factors of surgical site infection after hysterectomy for endometrial carcinoma: a retrospective analysis.

Authors:  Lijuan Shi; Qiao Gu; Fenghua Zhang; Daoyun Li; Wenfeng Ye; Yan Zhong; Xiu Shi
Journal:  BMC Surg       Date:  2021-06-14       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.